Skip to content
★ Sign in to follow
CO

Claudia Ordonez

Directeur Médical
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€241k

Latest filing published 15 Jun 2021 for Keros Therapeutics, Inc., €27k.

Filing timeline

BuySale
Claudia Ordonez

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

Claudia Ordonez: trading record in brief

All filings by Claudia Ordonez on record concern Keros Therapeutics, Inc., in the capacity of senior executive. Over a trading history stretching from 11 February 2021 to 11 June 2021, the count stands at 18 filings.

The open-market record consists of 13 sales worth €241k, with no purchase. Outside the open market, there are 5 option exercises.

The newest entry dates from 15 June 2021: an open-market sale of €27k, in Keros Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Claudia Ordonez

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

18 of 18 declarations